Sedative-hypnotic Effect of Ash of Silver in Mice: A Reverse Pharmacological Study

10.4103/2225-4110.129198

Deep Inder；Pawan Kumar

Ash of silver ； Pentobarbitone ； Sedation

Journal of Traditional and Complementary Medicine

4卷4期（2014 / 10 / 01）

268 - 271

英文

Ash of silver is used in traditional systems of medicine for various neurological conditions like insomnias, neuralgias, anxiety disorders, and convulsions. The present study was conducted to evaluate the sedative‑hypnotic activity of ash of silver in comparison to pentobarbitone (standard drug) in albino mice. The mice were divided into four groups as follows: Group 1 (control): Gum acacia [GA; 1% per os (p.o.)], group 2 (standard): Pentobarbitone [50 mg/kg intraperitoneal (i.p.)], group 3 (test): Ash of silver (50 mg/kg p.o.), and group 4: Ash of silver (50 mg/kg p.o.) given 30 min prior to administration of pentobarbitone (50 mg/kg i.p.). Time of onset, recovery, and total duration of loss of righting reflex were studied. Ash of silver (test) produced significant sedation (P ＜ 0.01) compared to control (GA 1%), but the effect was significantly less compared to that of standard pentobarbitone at the doses used. Also, significant potentiation (P ＜ 0.001) of the sedative-hypnotic effect of pentobarbitone was observed with the test drug.

1. Bajaj, S,Vohora, SB(1998).Analgesic effects of gold preparations used in Ayurveda and Unan‑‑Tibb.Indian J Med Res,108,10-11.
2. Chopra, A,Doiphode, W(2002).Ayurvedic medicine: Core concept, therapeutic principles, and current relevance.Med Clin North Am,86,75-89.
3. Chopra, RN(1982).Chopra’s indigenious drugs of India.Calcutta:Academic Publishers.
4. Ernst, E(2002).Heavy metals in traditional Indian remedies.Eur J Clin Pharmacol,57,891-896.
5. Gogtay, NJ,Bhatt, HA,Dalvi, SS,Kshirsagar, NA(2002).The use and safety of non‑allopathic Indian medicines.Drug Saf,25,1005-1019.
6. Hamilton, EJ,Minski, MJ,Cleary, JJ(1972).The concentration and distribution of some stable elements in healthy human tissues from United Kingdom.Sci Total Environ,1,341-374.
7. Inder, D,Rehan, HS,Bajaj, VK,Kumar, P,Gupta, N,Singh, J(2012).Analgesic activity and safety of ash of silver used in Indian system of medicine in mice: Areverse pharmacological study.Indian J Pharmacol,44,46-50.
8. Khanna, AT,Silvaraman, R,Vohora, SB(1997).Analgesic activity of silver preparations used in Indian system of medicine.Indian J Pharmacol,29,393-398.
9. Kim, KR,Owens, G,Naidu, R(2010).Effect of root‑induced chemical changes on dynamics and plant uptake of heavy metals in rhizosphere soils.Pedosphere,20,494-504.
10. Kim, YS,Song, MY,Park, JD,Song, KS,Ryu, HR,Chung, YH(2010).Subchronic oral toxicity of silver nanoparticles.Part Fibre Toxicol,7,1-11.
11. Klaassen, CD(2001).Heavy metals and heavy metal antagonists.Goodman and Gilman’s: The pharmacological basis of therapeutics,New York:
12. Kumar, A,Nair, AG,Reddy, AV,Garg, AN(2006).Bhasmas: Unique Ayurvedic Metallic–Herbal Preparations, Chemical Characterization.Biological Trace Element Research,109,231-235.
13. Kumar, A,Nair, AG,Reddy, AV,Garg, AN(2006).Availability of essential elements in bhasmas: Analysis of ayurvedic metallic preparations by INAA.J Radioanalyt Nucl Chem,270,173-180.
14. Lad, V(1998).The Complete Book of Ayurvedic Home Remedies.New York:Three Rivers Press.
15. Lankveld, DP,Oomen, AG,Krystek, P,Neigh, A,Troost‑de, Jong, A,Noorlander, CW(2010).The kinetics of the tissue distribution of silver nanoparticles of different sizes.Biomaterials,31,8350-8361.
16. Lynch, E,Braithwaite, R(2005).Areview of the clinical and toxicological aspects of ‘traditional’(herbal) medicines adulterated with heavy metals.Expert Opin Drug Saf,4,769-778.
17. Marley, RJ,Miner, LL,Wehner, JM,Collins, AC(1986).Differential effects of central nervous system depressants in long‑sleep and short‑sleep mice.J Pharmacol Exp Ther,238,1028-1033.
18. Mitra, A,Chakraborty, S,Auddy, B,Tripathi, P,Sen, S,Saha, AV(2002).Evaluation of chemical constituents and free radical scavenging activity of Swarnabhasma (gold ash), an Ayurvedic drug.J Ethnopharmacol,80,147-153.
19. Nadeem, A,Khanna, T,Vohora, SB(1999).Silver preparations used in Indian system of medicine: Neuropsychobehavioural effects.Indian J Pharmacol,31,214-221.
20. Nadkarni, AK(1986).Dr. K.M. Nadkarni’s Indian Materia Medica.Bombay:Popular Prakashan.
21. Overeem, S,Reading, P(2010).Effect of medication on sleep and wakefulness.Sleep disorders in neurology: A practical approach,UK:
22. Pattanaik, N,Singh, AV,Pandey, RS,Singh, BS,Kumar, M,Dixit, SK(2003).Toxicology and free radicals scavenging property of Tamra Bhasma.Indian J Clin Biochem,18,181-189.
23. Paul, S,Chugh, A(2011).Assessing the role of ayurvedic Bhasmas as ethno‑ nanomedicine in the metal based nanomedicine patent regime.J Intellect Property Rights,16,509-515.
24. Rizzi, A,Vergura, R,Marzola, G,Ruzza, C,Guerrini, R,Salvadori, S(2008).Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice.Br J Pharmacol,154,471-479.
25. Samudralwar, DL,Garg, AN(1996).Minor and trace elemental determination in the Indian herbal and other medicinal preparations.Biol Trace Elem Res,54,11-21.
26. Saper, RB,Kales, SN(2004).Heavy metal content of ayurvedic herbal medicine products.JAMA,292,2868-2873.
27. Tobler, I,Kopp, C,Deboer, T,Rudolph, U(2001).Diazepam‑induced changes in sleep: Role of the alpha 1 GABA (A) receptor subtype.Proc Natl Acad Sci U S A,98,6464-6469.
28. Yadav, SK(2010).Heavy metals toxicity in plants: An overview on the role of glutathione and phytochelatins in heavy metal stress tolerance of plants.S Afr J Bot,76,167-179.